Liquidia (NASDAQ:LQDA) Insider Sells $1,748,566.40 in Stock

Liquidia Corporation (NASDAQ:LQDA) insider Sarah Krepp sold 24,880 shares of Liquidia stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $70.28, for a total value of $1,748,566.40. Following the completion of the transaction, the insider owned 121,863 shares in the company, valued at $8,564,531.64. The trade was a 16.95% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Sarah Krepp also recently made the following trade(s):

• On Monday, June 1st, Sarah Krepp sold 276 shares of Liquidia stock. The stock was sold at an average price of $60.87, for a total value of $16,800.12.
• On Monday, April 13th, Sarah Krepp sold 4,557 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total value of $174,852.09.

Liquidia Price Performance

Shares of NASDAQ LQDA traded up $0.57 during mid-day trading on Monday, reaching $71.80. The company had a trading volume of 2,103,774 shares, compared to its average volume of 1,741,705. The stock has a market cap of $6.39 billion, a PE ratio of 512.89 and a beta of 0.57. The company has a 50-day moving average price of $49.85 and a two-hundred day moving average price of $40.96. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. Liquidia Corporation has a 1-year low of $11.85 and a 1-year high of $72.71.

Liquidia (NASDAQ:LQDA) last issued its earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.41 by $0.11. The business had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The company’s revenue for the quarter was up 4187.1% on a year-over-year basis. On average, equities analysts anticipate that Liquidia Corporation will post 2.97 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on LQDA shares. Wells Fargo & Company raised their target price on Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Liquidia in a research report on Tuesday, April 21st. Needham & Company LLC raised their target price on Liquidia from $54.00 to $70.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $60.00 target price on shares of Liquidia in a research report on Monday, May 11th. Finally, Oppenheimer set a $75.00 price objective on Liquidia in a research report on Friday, June 5th. Three research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $60.29.

Institutional Trading of Liquidia

Institutional investors have recently bought and sold shares of the company. Apis Capital Advisors LLC acquired a new stake in Liquidia during the third quarter valued at $9,569,000. Farallon Capital Management LLC boosted its position in Liquidia by 102.1% during the third quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock valued at $194,783,000 after purchasing an additional 4,326,876 shares during the last quarter. GSA Capital Partners LLP boosted its position in Liquidia by 63.6% during the fourth quarter. GSA Capital Partners LLP now owns 63,176 shares of the company’s stock valued at $2,179,000 after purchasing an additional 24,555 shares during the last quarter. Tudor Investment Corp ET AL acquired a new stake in Liquidia during the third quarter valued at $1,536,000. Finally, State of New Jersey Common Pension Fund D acquired a new stake in Liquidia during the fourth quarter valued at $709,000. Institutional investors and hedge funds own 64.54% of the company’s stock.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).